Search research articles
Contact Us
Filters
Showing results (51-60 of 145) with videos related to
Page
of 15
Sort By:
Klinische Wochenschrift
|
February 16, 1987
Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system
T Eisenhauer, V W Armstrong, H Wieland, et al.
Nephron
|
January 1, 1985
Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients
V W Armstrong, W Creutzfeldt, R Ebert, et al.
Therapeutic Drug Monitoring
|
April 1, 1995
Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure
U Lehmann, V W Armstrong, E Schütz, et al.
Transplantation
|
September 15, 1995
Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions
E Wieland, E Schütz, V W Armstrong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 1, 1995
The 17th annual meeting of the European Lipoprotein Club
A F Stalenhoef, V W Armstrong, A Steinmetz, et al.
Transplantation Proceedings
|
March 27, 2001
Monitoring of mycophenolic acid in pediatric renal transplant recipients
V W Armstrong, M Shipkova, E Schütz, et al.
European Journal of Endocrinology
|
December 24, 1997
The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial
W Nolte, C Rädisch, V W Armstrong, et al.
Cell Proliferation
|
July 2, 2010
Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus
F C Schultze, D T Petrova, M Oellerich, et al.
Transplantation Proceedings
|
March 20, 1999
Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite
M Shipkova, E Schütz, V W Armstrong, et al.
Zeitschrift Fur Gastroenterologie
|
June 1, 1996
Molecular basis of the interaction between LDL and recombinant apo(a)
M Helmhold, A Ernst, C Brunner, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 145) with videos related to
Sort By:
Page
of 15
Klinische Wochenschrift
|
February 16, 1987
Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system
T Eisenhauer, V W Armstrong, H Wieland, et al.
Nephron
|
January 1, 1985
Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients
V W Armstrong, W Creutzfeldt, R Ebert, et al.
Therapeutic Drug Monitoring
|
April 1, 1995
Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure
U Lehmann, V W Armstrong, E Schütz, et al.
Transplantation
|
September 15, 1995
Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions
E Wieland, E Schütz, V W Armstrong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 1, 1995
The 17th annual meeting of the European Lipoprotein Club
A F Stalenhoef, V W Armstrong, A Steinmetz, et al.
Transplantation Proceedings
|
March 27, 2001
Monitoring of mycophenolic acid in pediatric renal transplant recipients
V W Armstrong, M Shipkova, E Schütz, et al.
European Journal of Endocrinology
|
December 24, 1997
The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial
W Nolte, C Rädisch, V W Armstrong, et al.
Cell Proliferation
|
July 2, 2010
Differential proteome and phosphoproteome signatures in human T-lymphoblast cells induced by sirolimus
F C Schultze, D T Petrova, M Oellerich, et al.
Transplantation Proceedings
|
March 20, 1999
Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite
M Shipkova, E Schütz, V W Armstrong, et al.
Zeitschrift Fur Gastroenterologie
|
June 1, 1996
Molecular basis of the interaction between LDL and recombinant apo(a)
M Helmhold, A Ernst, C Brunner, et al.
Page
of 15